Brought to you by 
Dako to distribute ImmunoCyt in US for DiagnoCure
23 May 2002
Executive Summary
Dako Corp. (sells diagnostic products to labs and hospitals) will handle US distribution of DiagnoCure's ImmunoCyt urine test for early detection of superficial bladder cancer. The test identifies tumor cells by using monoclonal antibodies coupled with a fluorescent dye.
Deal Industry
-
In Vitro Diagnostics
- Urine-based Testing
Deal Status
- Terminated
Deal Type
-
Alliance
- Intra-Biotech Deal
- Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Dako to distribute ImmunoCyt in US for DiagnoCure
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice